Castle Biosciences Inc
F:086
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Castle Biosciences Inc (086) under the Base Case is 0.43 EUR per share.
Compared with the current market price of 0.8 EUR, the stock appears
Overvalued by 46% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Castle Biosciences Does
Castle Biosciences makes laboratory tests that help doctors make treatment decisions for cancers and other skin-related conditions. Its best-known products are molecular diagnostic tests, including tests for melanoma and other skin cancers, that analyze tissue samples and give doctors more information about how aggressive a disease may be and how a patient may respond to treatment.
- Headquarters
- United States of America US
- Employees
- 883
- IPO date
- Jul 25, 2019
Revenue & Expenses Breakdown
Castle Biosciences Inc
Earnings Waterfall
Castle Biosciences Inc
Continue Research
Decided on Castle Biosciences? Get an email when Castle Biosciences Inc reaches the price you’d buy at. Free with an account.
Other Castle Biosciences listings
What is the Intrinsic Value of one Castle Biosciences Inc stock?
The intrinsic value for
Castle Biosciences Inc (086) under the Base Case is 0.43 EUR.
Is Castle Biosciences Inc stock undervalued or overvalued?
Compared with the current market price of 0.8 EUR, the stock appears Overvalued by 46% .